by Shay Zakov | In this work, we review the reports provided by Pfizer to the FDA for the trial’s first interim analysis. The reports demonstrate severe flaws in the procedure of approving Pfizer’s Covid-19 vaccine based on data from the vaccine’s phase III clinical trial.
ARTICLES
Understanding Relative Risk Reduction (RRR) and Absolute Risk Reduction (ARR) in Vaccine Trials
by Ivan Iriarte MD, Simon Phoenix PhD | In broad terms, the ARR compares how much the overall probability of an outcome reduced or increased. The RRR just compares the benefit, no matter how small, of one event versus another.